A Study of the Time to Diagnosis by Hand-held Abdominal Ultrasound in In-patient Settings
1 other identifier
interventional
226
1 country
1
Brief Summary
The goal of this study is to investigate the impact of integrating handheld abdominal ultrasound into the current gastroenterology and hepatology consultation model at our hospital, particularly in terms of the speed of diagnostic evaluation and the impact of hospital length of stay.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 8, 2024
CompletedStudy Start
First participant enrolled
December 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2025
CompletedFirst Posted
Study publicly available on registry
March 27, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2026
CompletedAugust 12, 2026
March 1, 2026
12 months
August 8, 2024
August 9, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Time to diagnostic imaging
This outcome evaluates the clinical efficiency of the diagnostic workflow by measuring the time interval (in minutes) required to complete the initial diagnostic imaging. The exact measurement endpoints are defined by the study arm: Start point (Both arms): The exact time the gastroenterology consultation is initiated. End point (Intervention group): Defined as the interval from the consultation request to the first modality that established the correct diagnosis of the targeted organs matching the final electronic medical record. If the bedside POCUS findings accurately identified the primary pathology, the POCUS timestamp was used; otherwise, the timestamp of the subsequent formal radiology report was utilized. End point (Control group): The execution of the first formally scheduled diagnostic imaging study (e.g., computed tomography \[CT\], magnetic resonance imaging \[MRI\], or conventional cart-based ultrasound) ordered as part of standard care following the consultation.
From the initiation of the consultation to the execution of the diagnostic imaging study, assessed up to hospital discharge (an average of 14 to 30 days).
Secondary Outcomes (2)
Post-Consultation Hospital Length of Stay (LOS)
From the initiation of the gastroenterology consultation to the date of hospital discharge, assessed up to a maximum of 1 year.
Diagnostic Accuracy of the Targeted Organ by Handheld Ultrasound Device (HUD)
From the time of initial HUD evaluation up to hospital discharge (an average of 2 to 4 weeks).
Study Arms (2)
Handheld Ultrasound/POCUS Arm
EXPERIMENTALControl Arm
NO INTERVENTIONInterventions
A handheld portable ultrasound sponsored by Aco Healthcare Co., Ltd company
Eligibility Criteria
You may qualify if:
- \- Patients aged over 18 who are hospitalized and requiring for a gastroenterology consultation or abdominal ultrasound, including cases of abdominal pain, diarrhea, abnormal liver function, unexplained fever, or evaluating intra-abdominal lesions.
You may not qualify if:
- Patients unable to comply with handheld ultrasound examination.
- Patients who are in the intensive care unit.
- Patients who had already undergone formal abdominal imaging within one week prior to the consultation.
- Patients who referred for immediate endoscopic intervention, such as active gastrointestinal bleeding or foreign body ingestion.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- National Taiwan University Hospitallead
- Aco Healthcare Co., Ltd.collaborator
Study Sites (1)
National Taiwan University Hospital
Taipei, 10002, Taiwan
Related Publications (1)
Barreiros AP, Dong Y, Ignee A, Wastl D, Dietrich CF. EchoScopy in scanning abdominal diseases; a prospective single center study. Med Ultrason. 2019 Feb 17;21(1):8-15. doi: 10.11152/mu-1907.
PMID: 30779825RESULT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 8, 2024
First Posted
March 27, 2026
Study Start
December 15, 2024
Primary Completion
November 30, 2025
Study Completion
May 31, 2026
Last Updated
August 12, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share
Available from the corresponding author upon reasonable request.